Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France

The following errors were present in the original published version of this article.

In the Introduction, ‘ventilator-acquired pneumonia’ should have read ‘ventilator-associated pneumonia’.

In Table 3, the MIC₉₀ of ceftolozane/tazobactam for Proteus spp. appeared as ‘0.35’ but should have read ‘0.5’.

In Table 3, the percentage susceptibility of S. maltophilia to meropenem appeared as ‘94.9’ but should have read ‘4.9’.

These errors have now been corrected in the published version of the article.

The authors apologize for these errors.

 

JAC Antimicrob Resist 2021; 3: https://doi.org/10.1093/jacamr/dlab081